US Stock MarketDetailed Quotes
KZIA Kazia Therapeutics
- 0.896
- -0.344-27.76%
Close Jul 12 16:00 ET
- 0.840
- -0.056-6.23%
Post 19:59 ET
26.69MMarket Cap-2376P/E (TTM)
1.105High0.861Low25.62MVolume1.070Open1.240Pre Close24.88MTurnover96.71%Turnover RatioLossP/E (Static)29.79MShares1.58052wk High7.47P/B23.73MFloat Cap0.18752wk Low--Dividend TTM26.49MShs Float15.850Historical High--Div YieldTTM19.67%Amplitude0.187Historical Low0.971Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Kazia Therapeutics Stock Forum
The $Dow Jones Industrial Average(.DJI.US)$surged to a new record, closing up 247.15 points (0.62%) at 40,000.90. The $S&P 500 Index(.SPX.US)$ and $Nasdaq Composite Index(.IXIC.US)$ also saw gains of 0.55% and 0.63% respectively. This rally was driven by positive investor sentiment despite mixed economic signals.
Key Stock Movements
• eVTOL Stocks: $Joby Aviation(JOBY.US)$ soared nearly 28% and $Archer Aviation(ACHR.US)$ rose over...
Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, has recently announced findings from a Phase II/III clinical trial evaluating their novel drug, paxalisib, for the treatment of glioblastoma. Glioblastoma is a highly aggressive and life-threatening brain cancer, representing one of th...
No comment yet